0.5711
price up icon0.18%   +0.001
after-market  시간 외 거래:  .5996  0.0285   +4.99%
loading

DermTech Inc 주식(DMTK)의 최신 뉴스

Selling Buzz: DermTech Inc [DMTK] Chief Financial Officer Sun Kevin M sells 447 shares of the company – Knox Daily - Knox Daily

pulisher
Knox Daily

Charting the Course: DermTech Inc’s DMTK Stock Prospects - The InvestChronicle

pulisher
The InvestChronicle

DermTech Reports First-Quarter 2024 Financial Results - Business Wire

pulisher
Business Wire

Is DiaMedica Therapeutics (DMAC) Stock Outpacing Its Medical Peers This Year? - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

DermTech, Inc. (DMTK) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Singapore News

pulisher
Yahoo Singapore News

DermTech, Inc. (DMTK) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

Savant Capital LLC Buys New Holdings in DermTech, Inc. (NASDAQ:DMTK) - Defense World

pulisher
Defense World

Emerging Trends of Dermatology Telehealth Market | OnlineDoctor, DermTech, Hims & Hers - Motions Online

pulisher
Motions Online

DermTech to Present at the William Blair Growth Stock Conference - The Globe and Mail

pulisher
The Globe and Mail

What Analysts Are Saying About DermTech Stock

pulisher
Benzinga

What Analysts Are Saying About DermTech Stock - DermTech (NASDAQ:DMTK) - Benzinga

pulisher
Benzinga

DermTech explores strategic alternatives, plans major layoffs By Investing.com - Investing.com

pulisher
Investing.com

DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and ... - Business Wire

pulisher
Business Wire

Stephens cuts DermTech stock target to $1.50, keeps Equal Weight rating - Investing.com

pulisher
Investing.com

DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

pulisher
Yahoo Finance

DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates

pulisher
Zacks Investment Research

DermTech reports Q4 EPS (56c), consensus (56c) - TipRanks.com - TipRanks

pulisher
TipRanks

DocGo Inc. (DCGO) Q4 Earnings Lag Estimates

pulisher
Zacks Investment Research

DermTech COO Claudia Ibarra to Depart in February 2024 - TipRanks.com - TipRanks

pulisher
TipRanks

DermTech Inc Announces Cost-Cutting Restructuring Plan - TipRanks.com - TipRanks

pulisher
TipRanks

DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations - Business Wire

pulisher
Business Wire

DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across ... - Yahoo Finance

pulisher
Yahoo Finance

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay - Business Wire

pulisher
Business Wire

DermTech's cancer test has 99% accuracy in ruling out melanoma - Clinical Trials Arena

pulisher
Clinical Trials Arena

SHAREHOLDER ALERT: Levi & Korsinsky Notifies DermTech, Inc.(DMTK) Investors of a Class Action Lawsuit and ... - PR Newswire

pulisher
PR Newswire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DermTech, Inc. of a Class Action Lawsuit and a ... - PR Newswire

pulisher
PR Newswire

DERMTECH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed ... - GlobeNewswire

pulisher
GlobeNewswire

DermTech, Inc. (NASDAQ:DMTK) Q3 2023 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

DermTech Inc (DMTK) Reports 10% Increase in Total Revenue for Q3 2023 - Yahoo Finance

pulisher
Yahoo Finance

DMTK INVESTOR NEWS: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to ... - Markets Insider

pulisher
Markets Insider

DMTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DermTech, Inc. Investors with ... - PR Newswire

pulisher
PR Newswire

DermTech Stock: New CEO, Same Challenges (NASDAQ:DMTK) - Seeking Alpha

pulisher
Seeking Alpha

Zura Bio Announces Appointment of Chief Scientific Officer - Business Wire

pulisher
Business Wire

PACB: RIP to These 3 Dying Medical Stocks - StockNews.com

pulisher
StockNews.com

New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin ... - Business Wire

pulisher
Business Wire

DermTech to Present Four New Posters and Demonstrate its Smart Stickers™ at the 2023 American Academy of ... - Business Wire

pulisher
Business Wire

This Under-the-Radar Stock Has Tripled in 2023 -- and Could Have More Room to Run - The Motley Fool

pulisher
The Motley Fool

Can DermTech Recover From Its 85% Tumble? - TheStreet

pulisher
TheStreet

Health Tech Company Hopes To Transform Skin Cancer Testing In America With A Sticker - Forbes

pulisher
Forbes

Smart Stickers Can Now Test for Skin Cancer. Here's How They Work - NBC Washington

pulisher
NBC Washington

DermTech slips 14% after company misses Q3 2021 estimates, lowers revenue outlook - Seeking Alpha

pulisher
Seeking Alpha

3 Things About DermTech That Smart Investors Know - The Motley Fool

pulisher
The Motley Fool

How DermTech Could Change Skin Cancer Testing -- Or Fizzle Out - The Motley Fool

pulisher
The Motley Fool

DermTech Stock: Set To Become A Leader In Skin Diagnostics (NASDAQ:DMTK) - Seeking Alpha

pulisher
Seeking Alpha

Why Shares of DermTech Dropped 19% in July - The Motley Fool

pulisher
The Motley Fool

DermTech Stock: Disrupting Skin Cancer Testing (NASDAQ:DMTK) - Seeking Alpha

pulisher
Seeking Alpha

Why DermTech Stock Was Climbing Today - The Motley Fool

pulisher
The Motley Fool

Dermtech sees promising growth prospects despite COVID-19 - BioWorld Online

pulisher
BioWorld Online
diagnostics_research LH
$213.13
price down icon 0.04%
$114.46
price down icon 0.48%
diagnostics_research WAT
$360.51
price down icon 0.35%
$315.83
price down icon 1.86%
diagnostics_research MTD
$1,530.55
price up icon 0.70%
diagnostics_research IQV
$235.00
price up icon 0.56%
자본화:     |  볼륨(24시간):